Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States

American Journal of Public Health

Volumn 104, Issue 2, 2014, Pages

  Keyes, Katherine M ^a   Cerdá, Magdalena ^a   Brady, Joanne E ^b   Havens, Jennifer R ^c   Galea, Sandro ^a  

^a Mailman School of Public Health ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; ECONOMICS; FAMILY RELATION; HUMAN; OPIATE ADDICTION; PERCEPTION; PRESCRIPTION DRUG DIVERSION; PREVALENCE; PSYCHOLOGICAL ASPECT; RISK FACTOR; RURAL POPULATION; SOCIAL ENVIRONMENT; SOCIAL SUPPORT; STATISTICS; UNITED STATES; URBAN POPULATION;

ECONOMICS; FAMILY RELATIONS; HUMANS; OPIOID-RELATED DISORDERS; PERCEPTION; PRESCRIPTION DRUG DIVERSION; PRESCRIPTION DRUGS; PREVALENCE; RISK FACTORS; RURAL POPULATION; SOCIAL ENVIRONMENT; SOCIAL SUPPORT; UNITED STATES; URBAN POPULATION;

EID: 84893430391     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2013.301709     Document Type: Article

References (130)

1. National Institute on Drug Abuse. Prescription Drugs: Abuse and Addiction.Washington, DC: US Department of Health and Human Services; 2011.
2. Warner M, Chen LH, Makuc DM. Increase in Fatal Poisonings Involving Opioid Analgesics in the United States, 1999-2006. Hyattsville, MD: National Center for Health Statistics; 2009.
3. Substance Abuse and Mental Health Services Administration. Results From the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD; 2011.
4. Blanco C, Alderson D, Ogburn E, et al. Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend. 2007;90(2-3):252-260.
5. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug Alcohol Depend. 2003;69 (3):215-232.
6. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004;28(2): 176-188.
7. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283(13):1710-1714.
8. Paulozzi LJ. Opioid analgesic involvement in drug abuse deaths in American metropolitan areas. Am J Public Health. 2006;96(10):1755-1757.
9. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15(9):618-627.
10. Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31(6):506-511.
11. Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf. 2008;17 (10):997-1005.
12. Diez Roux AV. Complex systems thinking and current impasses in health disparities research. Am J Public Health. 2011;101(9):1627-1634.
13. Havens JR, Oser CB, Leukefeld CG, et al. Differences in prevalence of prescription opiate misuse among rural and urban probationers. Am J Drug Alcohol Abuse. 2007;33(2):309-317.
14. US Census Bureau. Metropolitan and micropolitan statistical areas main. 2013. Available at: Http://www. census.gov/population/metro. Accessed November 7, 2013.
15. Wunsch MJ, Nakamoto K, Behonick G, Massello W. Opioid deaths in rural Virginia: A description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict. 2009;18(1):5-14.
16. Cicero TJ, Surratt H, Inciardi JA, Munoz A. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf. 2007;16 (8):827-840.
17. McCauley JL, Danielson CK, Amstadter AB, et al. The role of traumatic event history in non-medical use of prescription drugs among a nationally representative sample of US adolescents. J Child Psychol Psychiatry. 2010;51(1):84-93.
18. Centers for Disease Control and Prevention. Drug overdose deaths-Florida, 2003-2009. MMWR Morb Mortal Wkly Rep. 2011;60(26):659-672.
19. Dew B, Elifson K, Dozier M. Social and environmental factors and their influence on drug use vulnerability and resiliency in rural populations. J Rural Health. 2007;23(suppl):16-21.
20. Havens JR, Young AM, Havens CE. Nonmedical prescription drug use in a nationally representative sample of adolescents: Evidence of greater use among rural adolescents. Arch Pediatr Adolesc Med. 2011;165 (3):250-255.
21. Galea S, Ahern J, Vlahov D. Contextual determinants of drug use risk behavior: A theoretic framework. J Urban Health. 2003;80(4, suppl 3):iii50-iii58.
22. Zinberg NE. Drug, Set, and Setting. New Haven, CT: Yale University Press; 1984.
23. Krieger N. Theories for social epidemiology in the 21st century: An ecosocial perspective. Int J Epidemiol. 2001;30(4):668-677.
24. Bronfenbrenner U. The Ecology of Human Development: Experiments by Nature and Design. Cambridge, MA: Harvard University Press; 1979.
25. Galea S, Nandi A, Vlahov D. The social epidemiology of substance use. Epidemiol Rev. 2004;26: 36-52.
26. Cerdá M, Tracy M, Messner SF, Vlahov D, Tardiff K, Galea S. Misdemeanor policing, physical disorder, and gun-related homicide: A spatial analytic test of "broken-windows" theory. Epidemiology. 2009;20 (4):533-541.
27. Nandi A, Glass TA, Cole SR, et al. Neighborhood poverty and injection cessation in a sample of injection drug users. Am J Epidemiol. 2010;171 (4):391-398.
28. Nandi A, Galea S, Ahern J, Bucciarelli A, Vlahov D, Tardiff K. What explains the association between neighborhood-level income inequality and the risk of fatal overdose in New York City? Soc Sci Med. 2006; 63(3):662-674.
29. Crawford ND, Ford C, Galea S, Latkin C, Jones KC, Fuller CM. The relationship between perceived discrimination and high-risk social ties among illicit drug users in New York City, 2006-2009. AIDS Behav. 2012;17(1): 419-426.
30. Furr-Holden CD, Milam AJ, Reynolds EK, Macpherson L, Lejuez CW. Disordered neighborhood environments and risk-taking propensity in late childhood through adolescence. J Adolesc Health. 2012;50(1): 100-102.
31. Suglia SF, Staudenmayer J, Cohen S, Enlow MB, Rich-Edwards JW, Wright RJ. Cumulative stress and cortisol disruption among Black and Hispanic pregnant women in an urban cohort. Psychol Trauma. 2010;2 (4):326-334.
32. Sheridan MJ. A proposed intergenerational model of substance abuse, family functioning, and abuse/neglect. Child Abuse Negl. 1995;19(5):519-530.
33. Anderson AR, Henry CS. Family system characteristics and parental behaviors as predictors of adolescent substance use. Adolescence. 1994;29(114):405-420.
34. Klagsbrun M, Davis DI. Substance abuse and family interaction. Fam Process. 1977;16(2):149-173.
35. Ledoux S, Miller P, Choquet M, Plant M. Family structure, parent-child relationships, and alcohol and other drug use among teenagers in France and the United Kingdom. Alcohol Alcohol. 2002;37(1):52-60.
36. Brown SA, McGue M, Maggs J, et al. A developmental perspective on alcohol and youths 16 to 20 years of age. Pediatrics. 2008;121(suppl 4):S290-S310.
37. Kandel D. Adolescent marihuana use: Role of parents and peers. Science. 1973;181(4104):1067-1070.
38. Smith KP, Christakis NA. Social networks and health. Annu Rev Sociol. 2008;34:405-429.
39. Dick DM, Agrawal A. The genetics of alcohol and other drug dependence. Alcohol Res Health. 2008;31 (3):111-118.
40. Urban NB, Martinez D. Neurobiology of addiction: Insight from neurochemical imaging. Psychiatr Clin North Am. 2012;35(2):521-541.
41. Hillemacher T. Biological mechanisms in alcohol dependence-new perspectives. Alcohol Alcohol. 2011;46(3):224-230.
42. Rahman S. Brain nicotinic receptors as emerging targets for drug addiction: Neurobiology to translational research. Prog Mol Biol Transl Sci. 2011;98: 349-365.
43. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, Baler R. Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays. 2010;32(9): 748-755.
44. Dayan J, Bernard A, Olliac B, Mailhes AS, Kermarrec S. Adolescent brain development, risk-taking and vulnerability to addiction. J Physiol Paris. 2010;104(5): 279-286.
45. Keyes KM, Keyes MA, March D, Susser E. Levels of risk: Maternal-, middle childhood-, and neighborhood-level predictors of adolescent disinhibitory behaviors from a longitudinal birth cohort in the United States. Ment Health Subst Use. 2011;4(1):22-37.
46. Fenton MC, Keyes K, Geier T, et al. Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction. 2011;107(3):599-609.
47. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62 (10):1097-1106.
48. Keyes KM, Martins SS, Hasin DS. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2008;97(1-2): 139-149.
49. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(7):830-842.
50. Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2005;66 (6):677-685.
51. Keyes KM, Schulenberg JE, O'Malley PM, et al. The social norms of birth cohorts and adolescent marijuana use in the United States, 1976-2007. Addiction. 2011;106(10):1790-1800.
52. Ghandour LA, Martins SS, Chilcoat HD. Understanding the patterns and distribution of opioid analgesic dependence symptoms using a latent empirical approach. Int J Methods Psychiatr Res. 2008;17(2): 89-103.
53. Martins SS, Storr CL, Zhu H, Chilcoat HD. Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population. Drug Alcohol Depend. 2009;99(1-3):58-67.
54. Edlund MJ, Martin BC, Fan MY, Devries A, Braden JB, Sullivan MD. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: Results from the TROUP study. Drug Alcohol Depend. 2010;112 (1-2):90-98.
55. Sung HE, Richter L, Vaughan R, Johnson PB, Thom B. Nonmedical use of prescription opioids among teenagers in the United States: Trends and correlates. J Adolesc Health. 2005;37(1):44-51.
56. Hall MT, Howard MO, McCabe SE. Prescription drug misuse among antisocial youths. J Stud Alcohol Drugs. 2010;71(6):917-924.
57. McCabe SE, Cranford JA, West BT. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys. Addict Behav. 2008;33(10):1297-1305.
58. Martins SS, Fenton MC, Keyes KM, Blanco C, Zhu H, Storr CL. Mood/anxiety disorders and their association with non-medical prescription opioid use and prescription opioid use disorder: Longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2012;42 (6):1261-1272.
59. Martins SS, Keyes KM, Storr CL, Zhu H, Chilcoat HD. Pathways between nonmedical opioid use/dependence and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2009; 103(1-2):16-24.
60. Boyd CJ, Teter CJ,West BT, Morales M, McCabe SE. Non-medical use of prescription analgesics: A three-year national longitudinal study. J Addict Dis. 2009;28 (3):232-242.
61. McCabe SE, Boyd CJ, Young A. Medical and nonmedical use of prescription drugs among secondary school students. J Adolesc Health. 2007;40(1):76-83.
62. McCabe SE, Teter CJ, Boyd CJ, Knight JR, Wechsler H. Nonmedical use of prescription opioids among U.S. college students: Prevalence and correlates from a national survey. Addict Behav. 2005;30(4): 789-805.
63. Department of Justice Drug Enforcement Administration. Automation of reports and consolidated orders system. Available at: Http://www.deadiversion. usdoj. gov/arcos. Accessed November 7, 2013.
64. Centers for Disease Control and Prevention. Vital signs: Overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487-1492.
65. Mularski RA, White-Chu F, Overbay D, Miller L, Asch SM, Ganzini L. Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med. 2006;21(6):607-612.
66. Lorenz KA, Sherbourne CD, Shugarman LR, et al. How reliable is pain as the fifth vital sign? J Am Board Fam Med. 2009;22(3):291-298.
67. Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Exp Clin Psychopharmacol. 2008;16(5):405-416.
68. Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: The results of an ultrarapid assessment. Pain Med. 2009;10(3):537-548.
69. Inciardi JA, Surratt HL, Cicero TJ, Kurtz SP, Martin SS, Parrino MW. The "black box" of prescription drug diversion. J Addict Dis. 2009;28(4):332-347.
70. Ward L, Patel NM, Hanlon A, Eldakar-Hein S, Sherlinski K, Ward SH. Prescription medication borrowing among adult patients at an urban medical center. J Urban Health. 2011;88(6):997-1014.
71. Carise D, Dugosh KL, McLellan AT, Camilleri A, Woody GE, Lynch KG. Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry. 2007;164(11):1750-1756.
72. Green TC, Grimes Serrano JM, Licari A, Budman SH, Butler SF. Women who abuse prescription opioids: Findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend. 2009;103(1-2):65-73.
73. Inciardi JA, Surratt HL, Cicero TJ, et al. Prescription drugs purchased through the Internet: Who are the end users? Drug Alcohol Depend. 2010;110(1-2):21-29.
74. Hempstead K. Manner of death and circumstances in fatal poisonings: Evidence from New Jersey. Inj Prev. 2006;12(suppl 2):ii44-ii48.
75. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613-2620.
76. Toblin RL, Paulozzi LJ, Logan JE, Hall AJ, Kaplan JA. Mental illness and psychotropic drug use among prescription drug overdose deaths: A medical examiner chart review. J Clin Psychiatry. 2010;71(4):491-496.
77. Forrester MB. Ingestions of hydrocodone, carisoprodol, and alprazolam in combination reported to Texas poison centers. J Addict Dis. 2011;30(2):110-115.
78. Substance Abuse and Mental Health Services Administration. Drug abuse warning network. 2012. Available at: Http://www.samhsa.gov/data/DAWN.aspx. Accessed November 7, 2013.
79. Substance Abuse and Mental Health Services Administration. National Household Survey on Drug Abuse. 2011. Available at: Http://oas.samhsa.gov/nsduh. htm. Accessed November 7, 2013.
80. National Drug Intelligence Center. National drug threat assessment. 2011. Available at: Http://www. justice.gov/archive/ndic/pubs44/44849/44849p.pdf. Accessed November 7, 2013.
81. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132(1-2): 95-100.
82. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future. National Survey Results on Drug Use, 1975-2009. Vol. 2: College Students and Adults Ages 19-50. Bethesda, MD: National Institute on Drug Abuse; 2010. NIH Publication 10-7585.
83. Foltin RW, Fischman MW. Self-administration of cocaine by humans: Choice between smoked and intravenous cocaine. J Pharmacol Exp Ther. 1992;261(3): 841-849.
84. Des Jarlais DC, Arasteh K, Perlis T, et al. The transition from injection to non-injection drug use: Longterm outcomes among heroin and cocaine users in New York City. Addiction. 2007;102(5):778-785.
85. Young AM, Havens JR, Leukefeld CG. Route of administration for illicit prescription opioids: A comparison of rural and urban drug users. Harm Reduct J. 2010;7:24.
86. Young AM, Havens Jr. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: A cross-sectional comparison and retrospective survival analysis. Addiction. 2012;107(3): 587-596.
87. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004;109(3): 514-519.
88. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18(12): 1166-1175.
89. Havens JR, Walker R, Leukefeld CG. Prescription opioid use in the rural Appalachia: A community-based study. J Opioid Manag. 2008;4(2):63-71.
90. McDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the US. J Pain. 2012;13 (10):988-996.
91. Barnard A. Prescription drug abuse: Florida's health crisis. Presented at the American Medical Association State Legislative Strategy Conference; January 3-5, 2013; Aventura, Florida. Available at: Http://www.ama-assn.org/resources/ doc/arc/no-index/2013-01-04-drug-diversion-abuse-benard.pdf. Accessed November 7, 2013.
92. Wininger PJ. Pharmaceutical overpromotion liability: The legal battle over rural prescription drug abuse. KY Law J. 2005;93(1):269.
93. Glasgow N. Rural/urban patterns of aging and caregiving in the United States. J Fam Issues. 2000;21 (5):611-631.
94. Hunsucker SC, Frank DI, Flannery J. Meeting the needs of rural families during critical illness: The APN's role. Dimens Crit Care Nurs. 1999;18(3):24-32.
95. Hoffman PK, Meier BP, Council Jr. A comparison of chronic pain between an urban and rural population. J Community Health Nurs. 2002;19(4):213-224.
96. Leff M, Stallones L, Keefe TJ, Rosenblatt R, Reeds M. Comparison of urban and rural non-fatal injury: The results of a statewide survey. Inj Prev. 2003;9(4): 332-337.
97. Coben JH, Tiesman HM, Bossarte RM, Furbee PM. Rural-urban differences in injury hospitalizations in the US, 2004. Am J Prev Med. 2009;36(1):49-55.
98. Leukefeld CG, Walker R, Havens JR, Leedham VT. What does the community say: Key informant perceptions of rural prescription drug use. J Drug Issues. 2007;37(3):503-524.
99. Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club-and street-based populations. Pain Med. 2007;8(2):171-183.
100. US Census Bureau. 2010 census data. Available at: Http://www.census.gov/ 2010census/data. Accessed November 7, 2013.
101. Rupasingha A, Goetz SJ, Freshwater D. Social and institutional factors as determinants of economic growth: Evidence from the United States counties. Pap Reg Sci. 2002;81(2):139-155.
102. McGranahan DA. How people make a living in rural America. In: Brown DL, Swanson LE, Barton AW, eds. Challenges for Rural America in the Twenty-First Century. University Park, PA: Pennsylvania State University Press; 2004:135-151.
103. Blackwell DL, McLaughlin DK. Do rural youth attain their educational goals? Rural Development Perspectives. 1999;12(2):37-44.
104. Roscigno VJ, Crowley ML. Rurality, institutional disadvantage, and achievement/attainment. Rural Sociol. 2001;66(2):268-292.
105. DeYoung AJ. Rural Education: Issues and Practice. New York, NY: Garland Publishing; 1991.
106. Beggs J, Haines V, Hurlbert J. Revisiting the rural-urban contrast: Personal networks in nonmetropolitan and metropolitan settings. Rural Sociol. 1996;61 (2):306-325.
107. Conger RD, Elder GH. Families in Troubled Times: Adapting to Change in Rural America. Hawthorne, NY: Aldine Transaction; 1994.
108. Turcotte M. Social engagement and civic participation: Are rural and small town populations really at an advantage? Rural Small Town Can Anal Bull. 2005;6(4): 1-24.
109. Singh K, Dika S. The educational effects of rural adolescents' social networks. J Res Rural Educ. 2003;18 (2):114-128.
110. Costa DL, Kahn ME. Civic engagement and community heterogeneity: An economist's perspective. Perspect Polit. 2003;1:103-111.
111. Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: A meta-analytic review. PLoS Med. 2010;7(7):e1000316.
112. Glasgow N. The Nonmetro Elderly: Economic and Demographic Status. Washington, DC: US Department of Agriculture, Economic Research Service; 1988. Rural Development Research Report 70.
113. Jonas AB, Young AM, Oser CB, Leukefeld CG, Havens Jr. OxyContin(R) as currency: OxyContin(R) use and increased social capital among rural Appalachian drug users. Soc Sci Med. 2012;74(10): 1602-1609.
114. Partidge MD, Rickman DS. High-poverty nonmetropolitan counties in America: Can economic development help? Int Reg Sci Rev. 2005;28:415-440.
115. Fuller CM, Borrell LN, Latkin CA, et al. Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health. 2005;95 (4):689-695.
116. Galea S, Ahern J, Tracy M, Vlahov D. Neighborhood income and income distribution and the use of cigarettes, alcohol, and marijuana. Am J Prev Med. 2007;32(6, suppl):S195-S202.
117. Hembree C, Galea S, Ahern J, et al. The urban built environment and overdose mortality in New York City neighborhoods. Health Place. 2005;11(2): 147-156.
118. Messner SF. Economic inequality and levels of homicide: An analysis of urban neighborhoods. Criminology. 1985;24(2):297-317.
119. Boardman JD, Finch BK, Ellison CG, Williams DR, Jackson JS. Neighborhood disadvantage, stress, and drug use among adults. J Health Soc Behav. 2001;42(2): 151-165.
120. Cerdá M, Buka SL, Rich-Edwards JW. Neighborhood influences on the association between maternal age and birthweight: A multilevel investigation of age-related disparities in health. Soc Sci Med. 2008;66(9):2048-2060.
121. Duncan SC, Duncan TE, Strycker LA. A multilevel analysis of neighborhood context and youth alcohol and drug problems. Prev Sci. 2002;3(2):125-133.
122. Hannon L, Cuddy MM. Neighborhood ecology and drug dependence mortality: An analysis of New York City census tracts. Am J Drug Alcohol Abuse. 2006;32 (3):453-463.
123. Cerdá M, Diez-Roux AV, Tchetgen ET, Gordon-Larsen P, Kiefe C. The relationship between neighborhood poverty and alcohol use: Estimation by marginal structural models. Epidemiology. 2010;21(4):482-489.
124. Galea S, Riddle M, Kaplan GA. Causal thinking and complex system approaches in epidemiology. Int J Epidemiol. 2010;39(1):97-106.
125. Gorevski E, Bian B, Kelton CM, Martin Boone JE, Guo JJ. Utilization, spending, and price trends for benzodiazepines in the US Medicaid program: 1991-2009. Ann Pharmacother. 2012;46(4):503-512.
126. Topel R. What have we learned from empirical studies of unemployment and turnover? Am Econ Rev. 1993;83(2):110-115.
127. Bluestone B. The great U-turn revisited: Economic restructuring, jobs, and the redistribution of earnings. In: Kasarda JD, ed. Jobs, Earnings, and Employment Growth Policies in the United States. Boston, MA: Kluwer Academic Publishers; 1990:7-43.
128. Centers for Disease Control and Prevention. Vital signs: Overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487-1492.
129. Keyes KM, Liu XC, Cerda M. The role of race/ethnicity in alcohol-attributable injury in the United States. Epidemiol Rev. 2012;34(1):89-102.
130. Ahern J, Galea S, Hubbard A, Midanik L, Syme SL. "Culture of drinking" and individual problems with alcohol use. Am J Epidemiol. 2008;167(9):1041-1049.